Update shared on 14 Dec 2025
Fair value Increased 8.33%Analysts have raised their price target on Implenia from CHF 48.00 to CHF 52.00, citing expectations of a more profitable earnings mix supported by higher projected profit margins and a lower implied future valuation multiple, despite moderating revenue growth assumptions and a slightly higher discount rate.
Valuation Changes
- Fair Value: Increased from CHF 48.00 to CHF 52.00, reflecting a modest upward revision in the intrinsic value estimate.
- Discount Rate: Risen slightly from 6.82 percent to 7.20 percent, implying a marginally higher required return and risk assessment.
- Revenue Growth: Reduced from 1.96 percent to 1.03 percent, signaling more conservative assumptions for top line expansion.
- Net Profit Margin: Increased significantly from 1.63 percent to 2.93 percent, indicating expectations of a more profitable earnings mix.
- Future P/E: Fallen markedly from 17.1x to 10.4x, suggesting a lower implied valuation multiple on anticipated earnings.
Have other thoughts on Implenia?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystLowTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystLowTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystLowTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.